| Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|---|---|---|---|---|---|
Net sales | ||||||
5,492 | 4,485 | 4,410 | 3,366 | 2,214 | 1,515 | 1,126 |
Cost of sales | ||||||
5,116 | 4,211 | 4,144 | 3,103 | 2,074 | 1,426 | 1,057 |
Gross profit | ||||||
376 | 274 | 265 | 263 | 140 | 89 | 69 |
Selling, general and administrative expenses | ||||||
335 | 255 | 213 | 217 | 127 | 77 | 64 |
Goodwill impairments | ||||||
224 | - | - | - | - | - | - |
Impairments of definite-lived intangible assets | ||||||
82 | - | 4 | - | - | - | - |
(Loss) income from operations | ||||||
-267 | 18 | 47 | 45 | 12 | 11 | 4 |
Other (expense) income: | ||||||
Interest expense | ||||||
41 | 10 | 6 | 5 | 2 | 1 | 1 |
Equity loss and impairment of non-consolidated entities | ||||||
-0 | - | -4 | - | -6 | -1 | -0 |
Change in fair value of redeemable common shares | ||||||
- | - | - | - | -9 | 34 | 6 |
Termination of existing stock redemption agreement | ||||||
- | - | - | - | 4 | - | - |
Other | ||||||
1 | 0 | 0 | 0 | 1 | 0 | 0 |
Total other expense | ||||||
-40 | -10 | -10 | -4 | -3 | -37 | -7 |
(Loss) income before income taxes | ||||||
-307 | 8 | 36 | 41 | 9 | -26 | -2 |
Income tax benefit (expense) | ||||||
-5 | -7 | 11 | 16 | 4 | - | - |
Net (loss) income | ||||||
-302 | 15 | 25 | 24 | 4 | -26 | -2 |
Less net loss attributable to noncontrolling interest | ||||||
- | -0 | -3 | -1 | -0 | - | - |
Net (loss) income attributable to Diplomat Pharmacy, Inc. | ||||||
-302 | 15 | 28 | 25 | 4 | -26 | -2 |
Other comprehensive (loss) income, net of tax | ||||||
-4 | - | - | - | - | - | - |
Total comprehensive (loss) income | ||||||
-306 | 15 | 28 | - | - | - | - |
Net income allocable to preferred shareholders | ||||||
- | - | - | - | 0 | - | - |
Net income allocable to common shareholders | ||||||
- | - | - | - | 4 | -26 | -2 |
Basic (in dollars per share) | ||||||
-4.07 | 0.23 | 0.43 | 0.42 | 0.12 | -0.79 | -0.08 |
Diluted (in dollars per share) | ||||||
-4.07 | 0.23 | 0.42 | 0.41 | 0.11 | -0.79 | -0.08 |
Basic (in shares) | ||||||
74 | 68 | 65 | 60 | 36 | 33 | 33 |
Diluted (in shares) | ||||||
74 | 68 | 68 | 63 | 38 | 33 | 33 |